Vertex Pharmaceuticals Incorporated
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
10,890.07 |
11,932.80 |
13,227.43 |
14,526.29 |
15,850.16 |
17,542.61 |
| Przychód Δ r/r |
0.00% |
9.58% |
10.85% |
9.82% |
9.11% |
10.68% |
| Przychód (min) |
10,840.03 |
11,474.24 |
12,036.30 |
14,428.91 |
15,071.40 |
16,680.70 |
| Przychód (max) |
10,970.15 |
12,768.41 |
14,478.98 |
14,623.67 |
16,869.80 |
18,671.12 |
| EBITDA (średnia) |
4,185.83 |
4,586.63 |
5,084.24 |
5,583.49 |
6,092.34 |
6,742.87 |
| EBIT (średnia) |
3,994.42 |
4,376.89 |
4,851.76 |
5,328.17 |
5,813.76 |
6,434.54 |
| EBIT % |
36.68% |
36.68% |
36.68% |
36.68% |
36.68% |
36.68% |
| Zysk netto (średni) |
132.03 |
4,619.59 |
4,426.59 |
5,263.62 |
6,799.94 |
7,447.58 |
| Zysk netto % |
1.21% |
38.71% |
33.47% |
36.24% |
42.90% |
42.45% |
| EPS (średnia) |
0.46 |
17.91 |
20.81 |
23.61 |
26.37 |
28.88 |
| Liczba analityków (Przychody) |
24 |
20 |
26 |
21 |
18 |
10 |
| Liczba analityków (EPS) |
19 |
19 |
21 |
11 |
5 |
4 |
| symbol |
VRTX |
VRTX |
VRTX |
VRTX |
VRTX |
VRTX |